Cultural Diversity in Clinical Research – Perspectives from Advocacy

 

Strategies on Securing Clinical Studies in the Top Therapeutic Areas: Part 2

Riley Krammer, Director of Sponsor and CRO Alliances | Mallory Thomas, Director of Site Relations

Strategies on Securing Clinical Studies in the Top Therapeutic Areas: Part 1

Riley Krammer, Director of Sponsor & CRO Alliances | Mallory Thomas, Director of Site Relations

2-minute read | Part 1 of 2

 

Analyzing insights and..

PI's and the “One and Done Syndrome” In Clinical Trials, Part 2

Authored by Joan Chambers, VP of Marketing & Strategy | Melissa Daley, Content Marketing Specialist

Part 2 of a 2-part series | 2-minute read

What is..

PIs and the “One and Done Syndrome” In Clinical Trials

Authored by Joan Chambers, VP of Marketing & Strategy | Melissa Daley, Content Marketing Specialist

Part 1 of a 2-part series | 3-minute read

Principal..

Technology Drives Rare Disease Research – Part 2

3 minute read

Three Days at MAGI

3 minute read

Technology Drives Rare Disease Research

3-minute read

Designing and conducting clinical trials comes with many inherent challenges and these are amplified when it comes to rare disease..

Healthcare Technology & Blockchain: Positive Disruption in Clinical Trials & Patient Experience

Authored By Melissa E. Daley, Content Marketing Specialist& Maggie Kilgallon, Marketing Coordinator

Most Popular